DNA XSONM
那斯達克 · USD
3.99
-0.04
(-0.87%)
收盤 10/07 03:43 (UTC+8)
10/07 03:43 (UTC+8)
DNA XSONM
3.99
-0.04
(-0.87%)
財務數據
損益表
- 0.17
- 0.12
- 0.15
- 0.15
- -
- -
- 0.44
- -0.44
- -
- -
- 24.91
- -31.35
- 30.44
- -0.25
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | -44,125 | 44,125 | - | - | 14,984 | 15,022 | 11,516 | 16,776 |
營業成本 | - | - | -33,108 | 33,108 | - | - | 15,167 | 10,790 | 8,547 | 13,874 |
營業毛利 | - | - | -11,017 | 11,017 | - | - | -183 | 4,232 | 2,969 | 2,902 |
營業費用 | 1,278 | 3,618 | -15,678 | 18,743 | 1,471 | 870 | - | 6,608 | - | 5,591 |
研發費用 | - | - | - | 2,723 | - | - | 12,507 | 715 | 557 | 456 |
推銷及管理費用 | 1,278 | 3,618 | -12,955 | 16,020 | 1,471 | 870 | 8,653 | 5,893 | 5,665 | 5,135 |
非經常性項目費用 | - | - | - | - | - | - | 761 | - | 3,217 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -1,278 | -3,618 | 4,661 | -7,726 | -1,471 | -870 | -22,104 | -2,376 | -6,470 | -2,689 |
其他收入及費用 | 180 | -227 | - | -340 | - | - | 449 | -19 | -92 | -92 |
利息費用 | 140 | 131 | 484 | 522 | 389 | 91 | 12 | - | 17 | - |
稅前純益 | -1,238 | -3,928 | 3,454 | -8,588 | -1,860 | -961 | -21,667 | -2,395 | -6,579 | -2,781 |
所得稅 | - | - | -361 | 361 | - | - | -53 | 117 | 37 | 125 |
稅後純益 | -1,247 | 6,340 | -8,887 | -4,753 | -7,475 | 458 | -21,614 | -2,512 | -6,616 | -2,906 |
基本每股稅後盈餘(元) | -0.92 | 5.01 | -27.60 | -0.27 | -0.79 | 0.08 | -6.40 | -0.52 | -0.14 | -0.06 |
稀釋每股稅後盈餘(元) | -1.12 | 5.01 | -27.52 | -0.15 | -0.99 | 0.08 | -4.55 | -0.49 | -0.14 | -0.06 |
基本平均股數(千股) | 1350.00 | 1265.00 | - | 17727.00 | 9509.00 | 105107.00 | 5020.00 | 87275.00 | 46853.00 | 44381.00 |
稀釋平均股數(千股) | 1350.00 | 1265.00 | - | 17727.00 | 9509.00 | 5839.00 | 5020.00 | 87275.00 | 46853.00 | 44381.00 |
還原基本每股稅後盈餘(元) | -0.92 | 5.01 | -27.60 | -4.83 | -14.15 | 1.41 | -115.26 | -9.36 | -25.38 | -11.70 |
還原稀釋每股稅後盈餘(元) | -1.12 | 5.01 | -27.52 | -2.71 | -17.84 | 1.41 | -81.83 | -8.88 | -25.92 | -11.70 |
還原基本平均股數(千股) | 1,350 | 1,265 | - | 984 | 528 | 5,839 | 278 | 4,848 | 260 | 246 |
還原稀釋平均股數(千股) | 1,350 | 1,265 | - | 984 | 528 | 324 | 278 | 4,848 | 260 | 246 |
EBITDA(千元) | -1,016 | 6,514 | -7,268 | -2,918 | -6,330 | 1,645 | -20,741 | -1,477 | -5,717 | -1,901 |